NOXBOX recalled 1,667 Nitric Oxide Delivery Systems on July 19, 2023. The recall addresses high failure rates of the internal Sample Pump. Patients should stop using the device immediately and follow manufacturer instructions.
Replacement of the internal Sample Pump due to high failure rates.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact NOXBOX LTD or your healthcare provider for instructions. Notification method: E-Mail
The recalled product is the NOxBOXi Nitric Oxide Delivery System. Model numbers include NOXBOXI, UDI: 05060541640009, and several serial numbers ranging from NI101034 to NI103146. The devices were distributed nationwide in the United States, specifically in Tennessee.
The recall stems from high failure rates of the internal Sample Pump. This defect poses a significant risk to patients relying on this medical device for nitric oxide delivery.
The recall is classified as Class II, indicating a potential for serious health consequences. No specific injury or incident numbers have been reported.
Stop using the device immediately. Patients and healthcare providers should follow the recall instructions provided by NOXBOX LTD. Contact them or your healthcare provider for further guidance.
For more information, email NOXBOX LTD. Visit the FDA recall page for additional details at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=Z-2544-2025.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.